시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 임상 데이터 관리 시스템(CDMS) 시장 보고서(2025년)
Clinical Data Management Systems (CDMS) Global Market Report 2025
상품코드 : 1824617
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

임상 데이터 관리 시스템(CDMS) 시장 규모는 앞으로 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 13.1%를 나타내 53억 4,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 리스크 기반 모니터링의 채용, 환자 중심의 시험 설계, 리얼 월드 에비던스(RWE)의 이용 증가, 임상시험의 세계화, 상호 운용성의 중시, 분산형 시험이나 가상 시험의 중시 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향으로는 전자 의료 기록(EHR)과의 통합, 데이터 분석의 인공지능, 위험 기반 모니터링, 모바일 건강(m 건강)의 통합, 데이터 프라이버시 규정에 대한 대응 등이 있습니다.

향후 5년간의 성장률 13.1%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 상승은 영국과 인도에서 조달하는 전자 데이터 수집(EDC) 플랫폼과 규제 준수 소프트웨어의 비용을 늘리고, 시험 비용을 악화시키고, 신약 개발 일정을 늦추는 것으로 미국의 임상 연구에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

임상 데이터 관리 시스템(CDMS) 시장 성장은 임상시험의 양과 복잡성 증가에 의해 촉진될 것으로 예측됩니다. 임상시험은 의학적, 외과적, 행동학적 개입을 평가하기 위해 수행되는 조사 연구이며, 분석을 위한 데이터의 정확한 수집, 통합 및 접근을 보장하기 위해 임상 데이터 관리 시스템에 크게 의존합니다. 이것은 신뢰성을 향상시키고 조사 결과를 도출하는 프로세스를 가속화합니다. 예를 들어 미국 정부의 웹 리소스인 ClinicalTrials.gov에 따르면 연구 결과를 발표한 임상시험의 수는 2022년 4,024건에서 2023년에는 5,063건으로 증가했으며, 임상시험의 양과 복잡성 증가가 임상 데이터 관리 시스템(CDMS) 시장 성장에 영향을 미치고 있다고 밝혔습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Clinical data management systems (CDMS) are specialized software applications crafted to oversee and process data from clinical trials, ensuring precision, thoroughness, and uniformity. CDMS plays a pivotal role in upholding data integrity, facilitating regulatory adherence, and streamlining data examination and reporting within clinical trials.

The primary variants of clinical data management systems (CDMS) include paper-based systems, electronic data capture systems, and hybrid systems. Paper-based systems involve the utilization of physical paper for the collection and documentation of data from clinical trial participants on Case Report Forms (CRF). These systems comprise software and services accessible through diverse deployment methods such as on-premise and cloud-based solutions. They serve a multitude of purposes including deployment in contract research organizations (CROs), medical device companies, pharmaceutical/biotechnology firms, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The clinical data management systems (CDMS) market research report is one of a series of new reports from The Business Research Company that provides clinical data management systems (CDMS) market statistics, including clinical data management systems (CDMS) industry global market size, regional shares, competitors with a clinical data management systems (CDMS) market share, detailed clinical data management systems (CDMS) market segments, market trends and opportunities, and any further data you may need to thrive in the clinical data management systems (CDMS) industry. This clinical data management system (CDMS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical data management systems (cdms) market size has grown rapidly in recent years. It will grow from $2.89 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to stringent regulatory requirements, growing volume of clinical data, focus on data accuracy and quality, rise in multicenter clinical trials, increased outsourcing of clinical trials.

The clinical data management systems (cdms) market size is expected to see rapid growth in the next few years. It will grow to $5.34 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to adoption of risk-based monitoring, patient-centric trial designs, increased use of real-world evidence (RWE), globalization of clinical trials, focus on interoperability, emphasis on decentralized and virtual trials. Major trends in the forecast period include integration with electronic health records (EHR), artificial intelligence in data analysis, risk-based monitoring, mobile health (mhealth) integration, compliance with data privacy regulations.

The forecast of 13.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. clinical research by driving up the cost of electronic data capture (EDC) platforms and regulatory compliance software sourced from the UK and India, exacerbating trial costs and delaying new drug development timelines. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the clinical data management systems (CDMS) market is expected to be propelled by the increasing volume and complexity of clinical trials. Clinical trials, which are research studies conducted to assess medical, surgical, or behavioral interventions, rely heavily on clinical data management systems to ensure the accurate collection, integration, and accessibility of data for analysis. This enhances the reliability and expedites the process of deriving research findings. For example, according to ClinicalTrials.gov, a US government web resource, the number of clinical trials publishing findings rose from 4,024 in 2022 to 5,063 in 2023, underscoring the influence of the growing volume and complexity of clinical trials on the CDMS market's growth.

Key players in the clinical data management systems (CDMS) market are concentrating on developing novel technologies, such as health intelligence platforms, to enhance their market profitability. A health intelligence platform is an integrated technological solution that harnesses data analytics and artificial intelligence to optimize the efficiency, accuracy, and insights derived from managing clinical trial data. For instance, in April 2023, Orion Health Group Limited, a healthcare software company based in New Zealand, introduced Orchestral. Orchestral represents a significant advancement in healthcare data management, offering a versatile platform supporting both cloud and on-premises configurations and integrating advanced features such as machine learning, natural language processing (NLP), and seamless data integration. This innovation is poised to revolutionize health data analytics, facilitating more informed decision-making in healthcare with unprecedented efficiency and flexibility.

In April 2022, Ennov Group, a France-based software company specializing in life sciences, acquired MACRO from Elsevier, a publishing company headquartered in the Netherlands, for an undisclosed sum. Through this acquisition, Ennov aims to enhance its suite of life sciences software by integrating MACRO's advanced electronic data capture (EDC) tools, thereby providing a more comprehensive and cost-effective solution for clinical research. MACRO, a product line of Elsevier, was an EDC software solution catering to the needs of clinical trials.

Major players in the clinical data management systems (CDMS) market are Oracle Corporation, IQVIA Inc., Dassault Systemes SE, PAREXEL International Corporation, Epic Systems Corporation, Veeva Systems Inc., Medical Information Technology Inc., Clario, Merative L.P., Medrio Inc., Forte Research Systems Inc., Ennov Group, Axiom Real-Time Metrics Inc., MedNet Solutions, eClinical Solutions LLC, Deep 6 AI, Applied Clinical Intelligence LLC, ClinCapture LLC, OpenClinica LLC, Datatrak International Inc., CIMS Global LLC, Novaseek Research Inc., Ofni Systems, OmniComm Systems Inc., and EvidentIQ.

North America was the largest region in the clinical data management systems market in 2024. The regions covered in clinical data management systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the clinical data management systems (CDMS) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical data management systems market consists of revenues earned by entities by providing services such as data collection, data validation, database design, query management, statistical analysis, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical data management systems market also includes sales of electronic data capture (EDC) systems, eCRF designers, clinical trial management systems, and reporting and analytics tools that are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Data Management Systems (CDMS) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical data management systems (cdms) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for clinical data management systems (cdms) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical data management systems (cdms) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Clinical Data Management Systems (CDMS) Market Characteristics

3. Clinical Data Management Systems (CDMS) Market Trends And Strategies

4. Clinical Data Management Systems (CDMS) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Clinical Data Management Systems (CDMS) Growth Analysis And Strategic Analysis Framework

6. Clinical Data Management Systems (CDMS) Market Segmentation

7. Clinical Data Management Systems (CDMS) Market Regional And Country Analysis

8. Asia-Pacific Clinical Data Management Systems (CDMS) Market

9. China Clinical Data Management Systems (CDMS) Market

10. India Clinical Data Management Systems (CDMS) Market

11. Japan Clinical Data Management Systems (CDMS) Market

12. Australia Clinical Data Management Systems (CDMS) Market

13. Indonesia Clinical Data Management Systems (CDMS) Market

14. South Korea Clinical Data Management Systems (CDMS) Market

15. Western Europe Clinical Data Management Systems (CDMS) Market

16. UK Clinical Data Management Systems (CDMS) Market

17. Germany Clinical Data Management Systems (CDMS) Market

18. France Clinical Data Management Systems (CDMS) Market

19. Italy Clinical Data Management Systems (CDMS) Market

20. Spain Clinical Data Management Systems (CDMS) Market

21. Eastern Europe Clinical Data Management Systems (CDMS) Market

22. Russia Clinical Data Management Systems (CDMS) Market

23. North America Clinical Data Management Systems (CDMS) Market

24. USA Clinical Data Management Systems (CDMS) Market

25. Canada Clinical Data Management Systems (CDMS) Market

26. South America Clinical Data Management Systems (CDMS) Market

27. Brazil Clinical Data Management Systems (CDMS) Market

28. Middle East Clinical Data Management Systems (CDMS) Market

29. Africa Clinical Data Management Systems (CDMS) Market

30. Clinical Data Management Systems (CDMS) Market Competitive Landscape And Company Profiles

31. Clinical Data Management Systems (CDMS) Market Other Major And Innovative Companies

32. Global Clinical Data Management Systems (CDMS) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Data Management Systems (CDMS) Market

34. Recent Developments In The Clinical Data Management Systems (CDMS) Market

35. Clinical Data Management Systems (CDMS) Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기